She Was Brave Enough To Deny FDA Approval On A Drug That Could Have Caused A Lot Of American Families Pain And Heartbreak

It’s fascinating to think about how far civilization has come regarding different kinds of medicine and how much further we can go.
Back in the 1950s and 60s, one woman was brave enough to deny FDA approval on a drug that could have caused a lot of American families a lot of pain and heartbreak.
That woman was Dr. Frances Kelsey, known in medical history as a hero for what she did while working for the U.S. Food and Drug Administration.
Frances was born in 1914 in Cobble Hill, British Columbia, Canada. She had an interest in science at a young age. By the time she was 20, she got her master’s degree from McGill University in Montreal before moving to Chicago, Illinois, and receiving a Ph.D. in pharmacology at the University of Chicago.
In 1942, Frances became a faculty member at the University of Chicago, where she met her husband, Dr. Fremont Kelsey, another staff member. Frances managed to earn her M.D. in 1950 while working at the university and took a brief position as an editorial associate for the American Medical Association Journal.
In 1960, Frances and her family moved to Washington, D.C., where she was hired as a drug reviewer for the FDA.
One of Frances’ very first assignments was to review an application submitted for the drug thalidomide. Years prior, thalidomide had been approved in several countries worldwide, including Germany, where it was sold over the counter.
Thalidomide was initially intended to be a sedative for those with anxiety before pregnant women were prescribed the drug to help with their morning sickness.
When thalidomide was submitted to the FDA for review by the company Richardson-Merrell, it was listed as a drug to help with morning sickness. Part of Frances’ job was to search through a ton of trial data and started showing concern about the lack of data surrounding thalidomide’s effect on pregnancies.

Diana Vyshniakova – stock.adobe.com – illustrative purposes only, not the actual person
She felt there was a significant lack of scientific evidence to prove the drug’s safety, so despite the pressure to approve it, she refused to.
Just one year after making her decision, researchers in Germany and Australia discovered a link between thalidomide and severe birth defects. Many children had been born with congenital limb anomalies, and the one thing they all had in common was that their mothers had taken thalidomide for morning sickness early in their pregnancies.
Frances was right, and she was a lifesaver.
Frances may not have received the credit she deserved for her outstanding work for the FDA if investigative journalist Morton Mintz hadn’t portrayed her as a hero in his front-page piece on the incident for The Washington Post in 1962.
That same year, President John F. Kennedy awarded Frances the President’s Award for Distinguished Federal Civilian Service by President John F. Kennedy.
She also witnessed President Kennedy sign the Kefauver-Harris amendments into law, which granted the FDA the power to demand a company submit sufficient proof of effectiveness for their drugs before they can be approved.
After her fascinating achievement, Frances continued working for the FDA for 45 years. She retired at the age of 90 and lived to be 101 years old, passing away in 2015 in London, Ontario, Canada.
It’s hard to imagine what could have happened if Frances didn’t trust her knowledge and instincts during her first year with the FDA, and we should be thankful for her to this day.
If true crime defines your free time, this is for you: join Chip Chick’s True Crime Tribe
She Vanished After Canceling A Trip To See Her Children And Taking A Bus To Tampa
He Left His Girlfriend For A Stunning Woman He Met On Vacation But Now He’s Missing His Old Life
Sign up for Chip Chick’s newsletter and get stories like this delivered to your inbox.
More About:Chicks We Love